Follow-up and adjustments Regular follow-up is a central part of treatment
Prinz, [email protected] These authors have contributed equally to this work Present addresses: Tatsuhi Ishimoto, Kochi National Hospital, Kochi, Japan Yukiyasu Arakawa, Department of Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan Secil Vural, Department of Dermatology, Ko University School of Medicine, Istanbul, Trkiye Katherina Siewart, Dermatotoxicology Study Centre, German Federal Institute for Risk Assessment, Department of Chemical and Product Safety, Berlin, Germany Rehab Alharbi, Dermatology Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Doses were adjusted with an FPG goal of 72 to 108 mg/dl in the study of DeVries et al., 72 to 90 mg/dl in the study of Aroda et al
Could you check if our company's Kaiser plan includes weight loss drug coverage
